Veris Health remote support to help underserved cancer patients during chemotherapy
Bridging the Gap: Enhancing Cancer Care for Underserved Populations with the Veris Health Cancer Care Platform
Using a phone- and web-based monitoring and communication tool to support underserved patients getting outpatient chemotherapy, especially those with language or technology barriers.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pavmed INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11196216 on NIH RePORTER |
What this research studies
You would use the Veris Health platform to report symptoms and stay connected with your oncology care team between visits. The team will adapt the platform so it is easy to use for people with limited English, limited access to smartphones or the internet, and other socioeconomic challenges. Researchers will work with community health centers, collect numbers on hospital and emergency visits, and conduct interviews with patients and providers to improve the system. The goal is to make the tool culturally and linguistically appropriate and reduce hospital stays, emergency visits, and financial strain.
Who could benefit from this research
Good fit: Adults receiving outpatient chemotherapy at participating community health centers who face language barriers, limited technology access, or other socioeconomic challenges would be ideal candidates.
Not a fit: People not receiving outpatient chemotherapy, those already well-supported by existing remote tools, or inpatient-only patients are unlikely to benefit from this specific program.
Why it matters
Potential benefit: If successful, the platform could help catch problems earlier, reduce emergency and hospital visits, and make cancer care easier and less costly for underserved patients.
How similar studies have performed: Related remote symptom-monitoring programs in cancer care have shown promise at improving symptom control and reducing emergency visits, but tailoring and validating them for underserved and non-English-speaking groups is less well studied.
Where this research is happening
New York, United States
- Pavmed INC. — New York, United States (Active)
Researchers
- Principal investigator: Deguzman, Brian — Pavmed INC.
- Study coordinator: Deguzman, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.